UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 249.60
-2.70 (-1.07%)
Mar 2, 2026, 5:38 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €48.03 billion as of March 2, 2026. Its market cap has increased by 40.64% in one year.
Market Cap
48.03B
Enterprise Value
47.91B
Revenue
7.74B
Ranking
n/a
PE Ratio
31.42
Stock Price
€249.60
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 48.03B, an increase of 5,292.39%. That is a compound annual growth rate of 13.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 48.03B | 5.95% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 40.23B |
| Financière de Tubize | 10.08B |
| Onward Medical | 235.24M |
| Hyloris Pharmaceuticals | 199.92M |
| European Medical Solutions | 23.02M |
| Celyad Oncology | 17.46M |
| BioSenic | 1.63M |
| Oxurion NV | 392.55K |